Balchem financials
$168.68+0.47%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.04B | $953.7M | $922.4M | $942.4M | $799.0M | $703.6M | $643.7M | $643.7M | $594.8M | $553.2M |
| Gross profit | $370.6M | $336.2M | $302.1M | $280.5M | $243.2M | $223.9M | $211.4M | $204.3M | $189.0M | $180.9M |
| Gross margin | 35.7% | 35.3% | 32.7% | 29.8% | 30.4% | 31.8% | 32.8% | 31.7% | 31.8% | 32.7% |
| Operating income | $209.3M | $182.9M | $159.2M | $145.2M | $127.5M | $111.1M | $102.6M | $107.1M | $96.9M | $90.8M |
| Net income | $154.8M | $128.5M | $108.5M | $105.4M | $96.1M | $84.6M | $79.7M | $78.6M | $90.1M | $56.0M |
| Net margin | 14.9% | 13.5% | 11.8% | 11.2% | 12.0% | 12.0% | 12.4% | 12.2% | 15.1% | 10.1% |
| Diluted EPS | $4.75 | $3.93 | $3.35 | $3.25 | $2.94 | $2.60 | $2.45 | $2.42 | $2.79 | $1.75 |
| EBITDA | $255.0M | $230.9M | $214.1M | $197.0M | $176.4M | $162.4M | $148.4M | $151.8M | $141.3M | $137.0M |
| Operating cash flow | $216.6M | $182.0M | $183.8M | $138.5M | $160.5M | $150.5M | $124.5M | $118.7M | $110.6M | $107.6M |
| Free cash flow | $173.1M | $146.3M | $145.9M | $88.6M | $123.2M | $116.7M | $96.0M | $99.0M | $82.5M | $84.6M |
| Diluted shares | 32.6M | 32.7M | 32.4M | 32.4M | 32.7M | 32.5M | 32.5M | 32.4M | 32.2M | 31.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $74.6M | $49.5M | $64.4M | $66.6M | $103.2M | $84.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $187.2M | $211.3M | $328.4M | $469.8M | $111.0M | $176.7M |
| Total assets | $1.69B | $1.58B | $1.60B | $1.62B | $1.20B | $1.17B |
| Total liabilities | $428.8M | $425.5M | $543.2M | $686.2M | $322.3M | $337.6M |
| Shareholders' equity | $1.26B | $1.15B | $1.05B | $938.3M | $877.0M | $828.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology